AAO Press Release on EyeArt® Clinical Trial Results: “Using AI to Screen for Diabetic Eye Disease Feasible in the Real World”

New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time. The system doesn’t require the input of an expert ophthalmologist

AAO Press Release on EyeArt® Clinical Trial Results: “Using AI to Screen for Diabetic Eye Disease Feasible in the Real World” Read More »